Daylight Photodynamic Therapy for Actinic Keratosis
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, single-blind controlled trial with parallel group design to determine
whether daylight photodynamic therapy (PDT) affords a reduction in treatment symptoms of
pain, burning, and pruritus as measured by 1) symptom level during the treatment period and
2) pain at the end of treatment exposure.